We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-6.69%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$4.66B
AUM Growth
-$1.07B
Cap. Flow
-$627M
Cap. Flow %
-13.47%
Top 10 Hldgs %
60.26%
Holding
100
New
3
Increased
16
Reduced
42
Closed
3

Top Buys

Rank Stock Value
1
RSG icon
Republic Services
RSG
+$77.1M
2
BSX icon
Boston Scientific
BSX
+$14.4M
3
AS icon
Amer Sports
AS
+$7.68M
4
INSM icon
Insmed
INSM
+$3.84M
5
PODD icon
Insulet
PODD
+$3.77M

Sector Composition

Rank Sector Weight
1 Financials 24.78%
2 Healthcare 17.99%
3 Technology 14.74%
4 Industrials 10.91%
5 Consumer Discretionary 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSM icon
26
Insmed
INSM
$22.5B
$26.3M 0.57%
161,110
+25,000
+18% +$3.84M
PEN icon
27
Penumbra
PEN
$12.6B
$23.6M 0.51%
72,000
GKOS icon
28
Glaukos
GKOS
$9.24B
$22.3M 0.48%
207,212
MDT icon
29
Medtronic
MDT
$113B
$22.1M 0.47%
255,000
PODD icon
30
Insulet
PODD
$11.8B
$21M 0.45%
99,908
+15,000
+18% +$3.77M
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$124B
$20.6M 0.44%
46,057
ELV icon
32
Elevance Health
ELV
$82.3B
$19M 0.41%
65,000
SCI icon
33
Service Corp International
SCI
$11.7B
$18.9M 0.41%
229,430
-16,998
-7% -$1.37M
META icon
34
Meta Platforms (Facebook)
META
$1.5T
$18.3M 0.39%
32,045
-6,299
-16% -$4.04M
KRYS icon
35
Krystal Biotech
KRYS
$10.6B
$17.5M 0.38%
67,809
-18,000
-21% -$4.79M
NBIX icon
36
Neurocrine Biosciences
NBIX
$18.2B
$16.5M 0.35%
125,000
SE icon
37
Sea Limited
SE
$66.1B
$16M 0.34%
193,607
-4,041
-2% -$433K
BMRN icon
38
BioMarin Pharmaceuticals
BMRN
$11.9B
$15.1M 0.32%
267,851
SNPS icon
39
Synopsys
SNPS
$72.3B
$14.8M 0.32%
37,365
-54
-0.1% -$24.4K
ALGN icon
40
Align Technology
ALGN
$12.9B
$14.3M 0.31%
83,428
CLH icon
41
Clean Harbors
CLH
$17.3B
$14.3M 0.31%
49,871
+1,602
+3% +$437K
MSCI icon
42
MSCI
MSCI
$42.5B
$13M 0.28%
24,208
-36
-0.1% -$20.3K
HSAI
43
Hesai Group
HSAI
$2.57B
$12.8M 0.28%
670,173
-26,960
-4% -$680K
RMD icon
44
ResMed
RMD
$31B
$12.6M 0.27%
55,939
-81
-0.1% -$20.2K
PRVA icon
45
Privia Health
PRVA
$3.07B
$12.5M 0.27%
610,000
FERG icon
46
Ferguson
FERG
$43.5B
$12.3M 0.26%
52,738
-77,024
-59% -$18.7M
PTC icon
47
PTC
PTC
$15B
$12M 0.26%
84,002
-120
-0.1% -$19K
PCVX icon
48
Vaxcyte
PCVX
$7.63B
$11.3M 0.24%
195,000
BSX icon
49
Boston Scientific
BSX
$68.8B
$11.3M 0.24%
+180,000
New +$14.4M
WAT icon
50
Waters Corp
WAT
$37.4B
$10.9M 0.23%
36,442
-51
-0.1% -$17.4K

Similar funds

C WorldWide Group's Q1 2026 Portfolio in Review

As of Q1 2026, C WorldWide Group held 100 positions worth $4.66B, down 19% from $5.73B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

C WorldWide Group withdrew a net $627M in Q1 2026, closing 3 positions and reducing 42 holdings. Its most notable exit was Procter & Gamble, an estimated $173M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, C WorldWide Group opened a new position in Boston Scientific worth $11.3M.

  • C WorldWide Group's largest Q1 2026 buy was Boston Scientific: 180,000 shares worth $11.3M.
  • C WorldWide Group added most to Republic Services in Q1 2026, an estimated $77.1M increase.
  • C WorldWide Group's biggest Q1 2026 reduction was Amazon, cutting an estimated $105M.
  • C WorldWide Group fully exited Procter & Gamble in Q1 2026, selling an estimated $173M.
  • C WorldWide Group's ten largest holdings make up 60% of its $4.66B portfolio in Q1 2026.
  • C WorldWide Group opened 3 new positions and closed 3 in Q1 2026.
  • C WorldWide Group's portfolio value fell 19% quarter-over-quarter to $4.66B.

Based on C WorldWide Group's 13F filing for Q1 2026, filed 6 May 2026.